Literature DB >> 17678474

Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy.

Chris A R Baker1, Nneka Emenyonu, Isaac Ssewanyana, Norman G Jones, Mohamed Elrefaei, Frehd Nghania, Justine Nakiwala, Irene Andia, Richard Clark, Jeffrey Martin, David R Bangsberg, Huyen Cao.   

Abstract

HIV infection is characterized by a decrease in total CD4 cell count, rising viral load, as well as an increase in immune activation levels. Increased activation can lead to an increase in apoptosis and contribute to CD4 depletion. We evaluated the clinical and immunologic responses of 23 HIV-positive Ugandan volunteers following initiation of antiretroviral therapy (ART). All volunteers achieved and maintained complete viral suppression within the first 3 months of therapy (p > 0.05). CD4+ and CD8+ T cell activation also decreased significantly, although it never reached the level of HIV negative Ugandan volunteers. Viral suppression and CD4 cell recovery were also associated with an improved profile in CD8+ T cell functional markers, but had no effect on HIV-specific proliferation. We conclude that ART in a cohort of therapy-naive Ugandans with AIDS partially restores but does not fully reverse the immune dysfunction observed in chronic HIV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17678474     DOI: 10.1089/aid.2006.0309

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  11 in total

1.  Therapeutic immunization in HIV infected Ugandans receiving stable antiretroviral treatment: a Phase I safety study.

Authors:  Cissy Kityo; Stephanie Bousheri; Juliette Akao; Francis Ssali; Rose Byaruhanga; Isaac Ssewanyana; Prossy Muloma; Sula Myalo; Rose Magala; Yichen Lu; Peter Mugyenyi; Huyen Cao
Journal:  Vaccine       Date:  2011-01-04       Impact factor: 3.641

2.  AIDSVAX immunization induces HIV-specific CD8+ T-cell responses in high-risk, HIV-negative volunteers who subsequently acquire HIV infection.

Authors:  Norman G Jones; Allan DeCamp; Peter Gilbert; Michael L Peterson; Marc Gurwith; Huyen Cao
Journal:  Vaccine       Date:  2008-12-09       Impact factor: 3.641

3.  Protective antigen-independent CD8 T cell memory is maintained during {gamma}-herpesvirus persistence.

Authors:  Stephanie S Cush; Emilio Flaño
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

4.  Infection with different hiv subtypes is associated with CD4 activation-associated dysfunction and apoptosis.

Authors:  Stephanie Bousheri; Candace Burke; Isaac Ssewanyana; Richard Harrigan; Jeffrey Martin; Peter Hunt; David R Bangsberg; Huyen Cao
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

5.  The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.

Authors:  Isaac Ssewanyana; Chris A R Baker; Theodore Ruel; Stephanie Bousheri; Moses Kamya; Grant Dorsey; Philip J Rosenthal; Edwin Charlebois; Diane Havlir; Huyen Cao
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

6.  Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.

Authors:  A S Walker; D Ford; C F Gilks; P Munderi; F Ssali; A Reid; E Katabira; H Grosskurth; P Mugyenyi; J Hakim; J H Darbyshire; D M Gibb; A G Babiker
Journal:  Lancet       Date:  2010-03-27       Impact factor: 79.321

7.  Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children.

Authors:  Theodore Ruel; Isaac Ssewanyana; Jane Achan; Anne Gasasira; Moses R Kamya; Adeodata Kekitiinwa; Joseph K Wong; Huyen Cao; Diane Havlir; Edwin D Charlebois
Journal:  Clin Immunol       Date:  2009-03-19       Impact factor: 3.969

8.  CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy.

Authors:  Jennifer Serwanga; Susan Mugaba; Auma Betty; Edward Pimego; Sarah Walker; Paula Munderi; Charles Gilks; Frances Gotch; Heiner Grosskurth; Pontiano Kaleebu
Journal:  AIDS Res Treat       Date:  2011-01-18

9.  High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.

Authors:  Damalie Nakanjako; Isaac Ssewanyana; Harriet Mayanja-Kizza; Agnes Kiragga; Robert Colebunders; Yukari C Manabe; Rose Nabatanzi; Moses R Kamya; Huyen Cao
Journal:  BMC Infect Dis       Date:  2011-02-08       Impact factor: 3.090

10.  Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans.

Authors:  Sarah Nanzigu; Ronald Kiguba; Joseph Kabanda; Jackson K Mukonzo; Paul Waako; Cissy Kityo; Fred Makumbi
Journal:  HIV AIDS (Auckl)       Date:  2013-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.